REVIEW article
Front. Mol. Biosci.
Sec. RNA Networks and Biology
Volume 12 - 2025 | doi: 10.3389/fmolb.2025.1459761
This article is part of the Research TopicExploring miRNA Roles in Cancer Pathogenesis and Treatment, Volume IIIView all articles
Role of miRNA in adult ocular tumorigenesis
Provisionally accepted- 1Department of Translational Medicine, University of Ferrara, Ferrara, Emilia-Romagna, Italy
- 2Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara, Emilia-Romagna, Italy
- 3Department of Environment and Prevention Sciences, University of Ferrara, Ferrara, Emilia-Romagna, Italy
- 4Research Department, King Khaled Eye Specialistic Hospital, Riyadh, Saudi Arabia
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
In recent years, cancer research has made huge advances also thanks to the discovery of the role of non-coding RNAs in the control of tumorigenesis, tumor proliferation, migration and metastasis and therefore also in the diagnosis and therapy of tumors. This work aims to review the most recent literature involving the study of miRNAs in ocular tumors affecting adult patients. We will introduce the role of miRNAs in tumorigenesis, and we will focus on summarizing the studies on uveal intraocular melanomas in which a role of microRNAs has been demonstrated. Similarly, we will also cover observations on miRNAs and eyelid cancers, especially sebaceous gland carcinoma, and cancers of the conjunctiva and the retina, excluding retinoblastoma which is typically a pediatric-onset tumor. We will summarize specific miRNAs that have potential as diagnostic molecules or as therapeutic targets against some ocular cancer diseases, indicating their potentialities and limitations, considering also their administration as nanomedicine for the eye.
Keywords: miRNA, Ocular tumors, Uveal Melanoma, Eye, retinal cancer, eyelid cancer, nanomedicine Article type: Review
Received: 04 Jul 2024; Accepted: 24 Apr 2025.
Copyright: © 2025 Romani, Melloni, Lodi, Bompan, Foschi, Zauli, Pozza, Secchiero, Zauli, Previati and Voltan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Maurizio Previati, Department of Translational Medicine, University of Ferrara, Ferrara, Emilia-Romagna, Italy
Rebecca Voltan, Department of Environment and Prevention Sciences, University of Ferrara, Ferrara, 44121, Emilia-Romagna, Italy
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.